Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
75Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $8.45B | $273.00M | $1.95 |
| 2024 | $7.08B | $54.08M | $0.37 |
| 2023 | $7.11B | $138.12M | $0.84 |
| 2022 | $7.93B | $286.22M | $2.00 |
| 2021 | $6.97B | $290.98M | $1.82 |
Social Signal Score
Earnings
Wed, Oct 28(in 2 months)
Consensus estimate $0.68 per share
Typical surprise +96.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$1.04 vs $0.86beat
- Wed, Apr 29$1.42 vs $0.62beat
- Wed, Feb 18$0.80 vs $0.36beat
- Wed, Oct 29$0.62 vs $0.32beat
- Tue, Jul 29$0.25 vs $0.28miss
- Wed, Apr 30$0.26 vs $0.07beat
Estimates and results for CSTM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CSTM's reported EPS growth of 1.7% a year over 4 years.
- EPS in 5 years
- $2.13
- Implied price
- $21.26
- Return from $29.60
- -6.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $10.57 — -64.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -8.3% | -23.8% | -19.3% | -15.6% | -12.5% | -9.7% |
| -3.3% | -19.6% | -14.9% | -11.0% | -7.7% | -4.8% |
| 1.7% | -15.5% | -10.5% | -6.4% | -2.9% | 0.1% |
| 6.7% | -11.3% | -6.1% | -1.8% | 1.8% | 5.0% |
| 11.7% | -7.2% | -1.7% | 2.8% | 6.6% | 10.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsseekingalpha.com·3d ago·Negative
Constellium: Downgrading To Hold, But Quality Remains Intact (Rating Downgrade) Constellium delivered record Q2 adjusted EBITDA, driven by robust aluminum pricing and disciplined execution, but faces near-term headwinds from falling commodity prices. CSTM raised guidance, expecting $980M–$1.02B in adjusted EBITDA and over $300M free cash flow, with 2028 targets now likely to be achieved ahead of schedule. I favor CSTM's quality and through-cycle economics over more levered peers, yet aluminum pr
View source ↗